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g.2012.0Abstract A common molecular variant of the angiotensinogen gene had been reported to predis-
pose some ethnic groups to hypertension. This case–control study was designed to determine the
frequency and association of the angiotensinogen M235T allele with hypertension in residents of
Calabar and Uyo cities, south–south Nigeria.
The study involved 1308 subjects, 612 patients and 696 controls. The M235T variant was inves-
tigated using an allele speciﬁc polymerase chain reaction and enzymatic digestion to determine allele
frequencies. Hypertensinogenic factors such as dietary habits, physical activity, smoking and drink-
ing habits were assessed using questionnaires. Descriptive statistics, chi-square and multiple regres-
sion analysis were used to analyze the data obtained.
The M235T allele frequency was high (0.94 for hypertensives and 0.96 for controls) though it was
not associated with hypertension status. The odds ratio for hypertension was 0.64 (95% conﬁdence
interval: 0.39–1.06) there were no signiﬁcant differences between the genotype frequency of hyper-
tensives and controls. By multiple regression, Hypertension was observed to be associated with age
and was a predictor for systolic blood pressure in both patient r2 = 0.359; p< 0.05 and control
groups r2 = 0.26.. of Genetics and Biotechnol-
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14 M.E. Kooffreh et al.Age and body mass index were predictors for diastolic blood pressure in the control group,
r2 = 0.28.
Although the frequency of the M235T variant was high, it was not a signiﬁcant risk factor for
hypertension in the study population.
 2012 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Hypertension is a multifactorial disorder because of the inter-
action of many risk genes such as molecular variants of the
angiotensinogen gene, angiotensin converting enzyme gene,
angiotensin II receptor I gene and the corin gene [1–4], and
environmental factors such as obesity, body mass index
(BMI), dietary salt intake, alcohol consumption, stress and
high-density lipid (HDL)–cholesterol levels. Genes determine
approximately 20–60% of the variability in blood pressure in
different populations [4,1].
Most studies so far have focused on the genes of the
renin–angiotensin–aldosterone system such as the M235T
variant in the angiotensinogen gene, which has been associ-
ated with increased circulating angiotensinogen levels and
blood pressure in many distinct populations [5–7] and a com-
mon variant in the angiotensin-converting enzyme (ACE)
gene that has been associated in some studies with blood
pressure variation in men [8,9]. However, these variants seem
to only modestly affect blood pressure, and other candidate
genes have not shown consistent and reproducible associa-
tions with blood pressure or hypertension in larger popula-
tions [10] thus, demonstration of common genetic causes of
hypertension in the general population remains elusive
[6,11,12].
The renin–angiotensin (R–A) system is a powerful pressure
system which inﬂuences salt and water homeostasis. Angioten-
sinogen (AGT) is a key component of this system, it is cleaved
by renin to yield angiotensinogen 1 (AGT 1), which is cleaved
by angiotensinogen converting enzyme (ACE) to yield angio-
tensinogen II (AGT II), responsible for carrying out a range
of functions that include prompting the constriction of blood
vessels causing a rise in blood pressure, ensuring the release
of aldosterone which induces an increase in the re-absorption
of sodium by the Kidneys [13].
Many research groups have reported that among the two
important molecular variants of AGT characterized so far,
the M235T allele is the predominant allele in Blacks
accounting for a frequency between 80% and 93% in the
population. Most of the studies carried out so far in Nigeria
have been concentrated in individuals and population in the
South Western part of the country. Little is found in
literature on hypertension in other geographical and ethnic
areas of Nigeria, and its genetic epidemiology, especially
since variations in the dietary intake, culture (way of life)
etc. exist in these places. In Blacks, differences have been
observed in the expression of risk factors such as level of
circulating angiotensinogen, urbanization, dietary factors
and metabolic disorder for hypertension depending on the
environment [14–16].
The aim of this study was to determine the frequency of the
M235T allele of the angiotensinogen gene and its association
with hypertension status in the study population.2. Subjects and methods
Venous blood (3 ml) was collected from each participant after
they had given informed consent, into bottles containing anti-
coagulant EDTA. Plasma was obtained by centrifugation of
blood samples. Blood and plasma were kept frozen in the free-
zer/cold room, then transported to the Department of Zoology
University of Ibadan where samples were kept at 70 C.
Samples were then transported to freezers in the International
Institute of Tropical Agriculture, Ibadan for subsequent lab
investigations. DNA was extracted from blood for angioten-
sinogen (AGT) genotyping. For some participants who refused
blood collection from the upper arm, blood was obtained from
thumb pricks and blotted onto a ﬁlter (Whatman, No. 3) pa-
per, allowed to dry at room temperature and preserved in plas-
tic bags prior to DNA extraction.
Participants included in the study gave informed consent
and ethical approval for the study was obtained from the joint
UI/UCH Ethics Review Committee and each of the health
establishment concerned – University Teaching Hospital Cala-
bar, University of Uyo Teaching Hospital and the General
Hospital, Calabar.
The wall in the collection centre was calibrated in meters.
Individuals stood without foot or head wear facing the inves-
tigator, looking straight ahead and the investigator placed a
ruler on top of the head of the individual and the reading in
meters was recorded. Using the conventional weight scale,
weight was measured in kilograms.
Blood pressure readings were taken using a sphygmoma-
nometer in millimeters of mercury systolic and diastolic BP
values were recorded. Before taking the measurement, the
respondent was advised to sit quietly for 5 min, with the legs
uncrossed and the right hand free from clothing. The right
hand was placed on the table with the palm facing upward.
The appropriate cuff size was selected and the cuff wrapped
and fastened securely. The cuff was kept at the same level as
the heart during measurement. The upper reading, the systolic
blood pressure (SBP) and lower reading the diastolic blood
pressure (DBP) were recorded, the ﬁrst and second readings
were taken twice and the average of the two used for the
analysis.
2.1. DNA extraction
DNA was extracted according to the method developed by
Dellaporta et al. [17] with a little modiﬁcation. The DNA
was re-suspended in 50 ll of Tris–EDTA buffer and stored
in the freezer as stock solution.
An aliquot of the DNA stock solution was run on agarose
gel electrophoresis to check the quantity of DNA. Each sample
of genomic DNA (5 ll) was mixed with 2 ll of loading dye and
transferred into the wells of the gel. A voltage of 110 V was
applied for about 45 min. The samples were scored +, 2+,
Figure 1 Agarose gel electrophoresis showing the ampliﬁcation
of the 165 bp fragment after enzymatic digestion with the Tth 1111
restriction endonuclease enzyme. Lane M is a 1 kb plus DNA
ladder; lane 1 is a 165 bp PCR product; lane 2 is a 141 bp digested
fragment showing a recessive homozygous individual; lanes 4 and
5 are 165 and 141 bp fragments showing a heterozygous individ-
ual; lane 12 is a 165 bp undigested fragment showing a normal
wild typa individual.
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amount of DNA extracted.
DNA was extracted from ﬁlter paper according to Bereczky
et al. [18]. Pieces (1–2) of the ﬁlter paper about 5 mm in diam-
eter were cut using a sterile blade for each samples. These
pieces were placed in an eppendorf tube, soaked in 65 ll of
T.E. buffer.
The tube was incubated at 50 C for 15 min in a water bath.
The pieces were pressed gently at the bottom of the tube sev-
eral times using a new pipette tip for each sample.
The eppendorf tubes were heated again for 15 min at 97 C
to elute the DNA. The liquid condensing on the lid and the
walls of the tube was removed by a short centrifugation
(2–3 s). The DNA extract that is the supernatant was kept at
20 C before use.
2.2. Polymerase chain reaction
Stock DNA samples were diluted to 1/10, 1/50, 1/100 depend-
ing on the amount of DNA in the sample checked after extrac-
tion. A 1/10 dilution was done for all ﬁlter paper extracted
DNA stock solutions.
Genomic DNA (2 ll) was ampliﬁed in a 15 ll reaction mix
containing Go Taq green master mix (Promega) 7.5 ll, up-
stream and downstream oligonucleotide primers 0.30 ll each
and 4.9 ll of nuclease-free water.
Cycling conditions: Below is the primer sequence used for
these experiments, an initial denaturation for 10 min at 95 C
was followed by 35 cycles of 1 min at 94 C, 1 min at 56 C
and 1 min 30 s at 72 Cand a ﬁnal elongation of 10 min at 72 C.
Primer sequence [19]
5l CAGGGTGCTGTCCACACTGGACCCC 3l
5l CCGTTTGTGCAGGGCCTGGCTCTCT 3l
2.3. Enzymatic digestion
The T235 variant of the AGT is induced by a single nucleotide
change from thymine to cytosine at position 704 near the 30
end of exon 2 of the angiotensinogen gene. The speciﬁc mis-
match incorporated into the antisense primer creates a Tth
111l site if the T235 variant is present (the presence of a cyto-
sine at position 704; GACNﬂNNGTC) the enzyme cuts the
PCR product into a 141 and a 24 bp fragment. If the 235 M
variant is present, (the presence of thymine at position 704;
GATNNNGTC) the enzyme does not cut, leaving a 165 bp
PCR product with no restriction fragments [20]. A cocktail
of 0.25 ll of the Tth111I enzyme, 1.5 ll of the 10· buffers
and 3 ll of sterile water was added to 10 ll of the PCR prod-
uct. The enzyme digestion was performed in a ﬁnal volume of
14.75 ll at 65 C for 2 h. The digested products were separated
on 3% agarose gel stained with 1.2 ll of ethidium bromide for
30 min at 125 V.
2.4. Data management
The Statistical Package for Social Sciences – SPSS for Win-
dows Version 11.0 was used to statistically analyze the data
obtained. Descriptive statistics was used to analyze all vari-
ables studied which include marital status, occupation, snack
use, smoking practices, alcohol consumption and AGT geno-type of the subjects. Genotype frequencies in control and
hypertensive groups were compared by chi-square analysis.
Continuous variables were compared between hypertensives
and controls by independent t test.
Effect of AGT genotype on BP was analyzed using a general
linear model. Inﬂuence of AGT genotype on continuous vari-
able was analyzed using one way ANOVA. Multiple regression
analysis was also carried out using SBP or DBP as dependent
variable, then sex, age, body mass index (BMI) and other vari-
ables were used as independent variables. P< 0.05 was consid-
ered statistically signiﬁcant.3. Results
3.1. Gel results
After digestion of the 165 bp PCR product with the Tth111I
enzyme, the normal individual M235M gives an undigested
165 bp, a mutant individual M235T gives two fragments of
141 bp and 24 bp. A recessive individual T235T gives a
141 bp fragment. However agarose gel allows the visualization
of a 165 bp fragment for M235M, a 141 bp fragment for
T235T, a 165 bp and 141 bp for the M235T individuals respec-
tively [19] Fig. 1.3.2. Demographic data
There were a total of 1308 subjects recruited into the study,
consisting of 612 hypertensives – 225 males and 387 females
and 696 normotensives – 273 males and 423 females. The Eﬁks
and the Ibibios (34.2; 32.4% respectively, n= 612) were the
main ethnic groups among the patients. The Ibibios (41.5%,
n= 696) were the predominant ethnic group among the con-
trols Fig. 2. Most individuals had the T235T variant of the
AGT gene in the ethnic groups of both the patient and the con-
trol population Figs. 3 and 4. The T235T allele was the pre-
dominant allele observed with a higher frequency among
females than males, Fig. 5.
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Figure 2 Ethnic distribution among patient and control groups.
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For patients the mean diastolic blood pressure was
93.25 ± 13.768, the mean systolic blood pressure was
161.14 ± 23.247. For the controls, the mean systolic blood
pressure was 116.76 ± 9.19; the mean diastolic blood pressure
was 72.181 ± 8.41. According to the seventh report of the
Joint National Committee of Prevention, Detection, Evalua-
tion and Treatment of High blood pressure (JNC VII) classiﬁ-
cation on hypertension, 281 patients had stage one
hypertension and 331 patients had stage two hypertension,
for the systolic BP measurement.Pe
rc
en
ta
ge
 %
Figure 3 Distribution of the AGT M235T allele aFrom the diastolic BP measurement, 381 patients were
grouped into the stage 1 category and 231 patients had stage
2 hypertension. For the systolic BP measurement in controls,
395 were classiﬁed into the prehypertension group while 301
were classiﬁed as normal. For the diastolic BP measurement,
309 controls were classiﬁed into the prehypertension group
and 387 controls as normal.
3.4. Age
The hypertensive subjects ranged from 24 to 90 years old with
a mean age of 51.3 years ± 13.76. Among the patient group,
464 (75.8%) persons were more than 40 years of age and 148
(24.2%) patients were less than 40 years. Normotensives ran-
ged from 20 to 73 years old with a mean age of
31.9 years ± 10.27, 569 (81.7%) controls were less than
40 years of age while 127 (18.3%) controls were above
40 years.
3.5. Body mass index
In the patient population, BMI below 24.9 kg/m2 was observed
in 234(38%) persons, BMI between 25 and 30 kg/m2 was ob-
served in 193(32%) persons and BMI above 30 kg/m2 was
found in 185(30%) persons. In the controls, BMI above
30 kg/m2 was found in 89(13%) persons, BMI between 25
and 30 kg/m2 was found in 140(20%) persons and a BMI be-
low 24.9 kg/m2 was observed in 467(67%) persons.
3.6. Genotype frequencies
The prevalence of AGT mutation was 88.4% for hypertensives
and 92.2% for controls (homozygous mutation), 10.9% hyper-
tensives and 7.5% control for the heterozygous mutation Ta-
ble 1. The wild type allele was prevalent at 0.3% and 0.7%
for patients and controls respectively. There were no signiﬁ-
cant differences between the genotype frequencies of hyperten-
sive and the control groups by v2 analysis. When continuous
variables were compared between hypertensive and controlMM
MT
TT
mong ethnic groups in the control population.
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Figure 4 Distribution of the AGT M235T allele among ethnic groups in the patient population.
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Figure 5 Distribution of the AGT M235T allele by gender in the
control and patient groups.
Using Hardy–Weinberg calculations for genotype and Allele frequency
Genotype frequencies of sample population
Patient MM MT TT
4 67 541
Control 2 52 642
Hardy–Weinberg calculations
M T MM MT TT
0.05 0.95 0.004 0.09 0.9 observed frequency
0.05 0.095 1.9 expected frequency according to Hardy–
Weinberg
Table 1 Genotype and allele frequency of the M235T
polymorphism of the angiotensinogen gene in the control and
patient populations.
Groups N Genotypes Alleles
MM MT TT M T
Hypertensives 612 4 67 541 37 575
% 0.7 10.9 88 6 94
Normotensives 696 2 52 642 28 66.2
% 0.3 7.5 92 4 96
A study of the A M235T variant of the angiotensinogen gene and hypertension 17groups, signiﬁcant differences existed between the age, BMI,
systolic and diastolic blood pressure of controls and patients.
By multiple regression analysis, age was the predictor for
SBP in the hypertensive group r2 = 0.359; p< 0.05. Age and
BMI were predictors for DBP in the control group, age was also
the predictor for SBP in the control group. Gender, body mass
index, and AGT genotype were not predictors for SBP and
DBP in the hypertensive group. The inﬂuence of AGT genotype
on continuous variable was compared using one way ANOVA.There were signiﬁcant differences in the age and systolic in the
control group and the systolic in the patient group but no sig-
niﬁcant differences between the continuous variation of other
groups. When blood pressure and other variables using general
linear model ANOVA were analyzed with no adjustments, age
was signiﬁcant for the MT and TT variables.The observed are not equal to those frequencies predicted
by Hardy–Weinberg which means there are evolutionary
mechanisms inﬂuencing the loci under consideration. Thus
the population does not meet the assumption of the Hardy–
Weinberg theory.
4. Discussion
The renin–angiotensin–aldosterone system plays a major role
in blood pressure regulation and AGT, a key substrate in this
pathway has been an attractive candidate gene for the study of
hypertension by many investigators [21–23]. Results have been
conﬂicting; some studies have indicated that the M to T amino
acid substitution at position 235 was associated with hyperten-
sion in several ethnic groups including Caucasian and Japanese
populations [24–26]. Other research groups have reported no
association of hypertension with the M235T variant.
The M235T allele is over 90% prevalent in the study pop-
ulation (0.94 for hypertensives and 0.96 for controls) which
is very high, this is consistent with literature. Nigerians have
been reported to have a high frequency of this molecular var-
iant, between 80% and 93% [27,28]. The frequency of the
M235T allele among hypertensive Malaysians was reported
as 0.45 and 0.75 among the Japanese [29,30].
18 M.E. Kooffreh et al.In this study, it was found that the M235T polymorphism
of the AGT gene is not associated with hypertension implying
that other polymorphisms are involved in the expression of the
phenotype. The odds ratio for hypertension is 0.64 95% CI
0.39 to 1.06. Association studies in Africans and African-
Americans also found a negative association [31,27] though
the T allele was associated with increased plasma AGT [32].
Jeunemaitre et al. [5] were the ﬁrst to report the linkage of
the molecular variant M235T with hypertension in Whites/
Caucasians. Subsequent studies among Whites/Caucasians
supported an association [33] while others did not support
any association [34,35].
Studies in the Japanese population found a positive associ-
ation between hypertension and the M235T variant with an
odds ratio of 2.67 [24,30]. Some other studies did not report
any association [36,37]. A study among Malaysian subjects
did not ﬁnd an association between hypertension and the
M235T allele [29]. Chinese and Taiwanese studies have also re-
ported positive associations [11,38]. The mechanism by which
the molecular variant M235T allele of the AGT gene is related
to hypertension is poorly understood. Although the AGT
235T allele was found to be in complete linkage disequilibrium
with a guanine to adenosine transition at 6 bp upstream of
the initiation site of transcription [21]. In vitro test of promoter
activity and DNA binding studies with nuclear proteins show
that this nucleotide substitution affects the basal transcription
rate of the gene in various cell lines thereby affecting the AGT
T235 variant, increased plasma AGT levels that might lead to
increased blood pressure [39].
The Eﬁks (384) and the Ibibios (487) made up the main eth-
nic groups in this study as is logical since the study was con-
ducted in Calabar and Uyo, Nigeria. Most patients were
married and advanced in age (above 40 years). Increase in
age is thought to increase blood pressure because the arteries
become hardened, less active, kidney function decreases and
the body does not process salt as well as before [40]. It was ob-
served that most young persons below the age of 40 years were
normotensives.
In the control population, more individuals (467) had the
normal body mass index which is P24.9 (67%), 140 controls
(20%) were overweight and 89 controls (13%) were obese. In
the patient population, 23(439%) patients had normal BMI
ofP24.9, more patients were overweight 193(38%) and obese
185(30%). Positive associations between body mass index and
blood pressure have been reported in cross sectional studies in
different populations [41–43].
Most females (both in controls and patients) were of the
T235T genotype. A study has indicated that homozygosity
for the T235 allele predicted risk for hypertension in women
and not in men [44]. This variant was also reported to be asso-
ciated with preeclampsia [45,19]. Markovic et al. [23] reported
an association of nucleotide base substitutions at position-6, -
29, -793, and -776 with hypertension in their study population.
Other studies provided no evidence for association with essen-
tial hypertension while stratifying for sex [35,34]. Age was the
predictor for SBP in the hypertensive group and was also the
predictor for SBP in the control group. Age and body mass in-
dex were predictors for DBP in the control group, age, gender,
body mass index, and AGT genotype were not predictors for
SBP and DBP in the hypertensive group. All other hypertensi-
nogenic factors considered did not contribute signiﬁcantly to
the disease when regression analysis was carried out.The population under study does not conform to the
Hardy–Weinberg equilibrium theory which means some evolu-
tionary forces are acting on the locus under consideration.
The results obtained from this study will form a baseline
information for these areas but more work still needs to be car-
ried out to look for other gene polymorphisms that could be
positive predictors for hypertension in this population.5. Conclusion
The M235T variant was investigated for an association with
hypertension in a sample population in Calabar and Uyo,
Nigeria. The frequency of the M235T variant of the AGT gene
is high particularly the AGT T235T homozygous genotype but
the M235T mutation is not an independent risk factor for
hypertension in individuals living within Calabar and Uyo.References
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